Maimun Zulhaidah Arthamin, Lydiana Parmadi, Dwi Priyadi Djatmiko, Elvin Richela Lawanto


Background. The diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) is required early and accurate to avoid missing diagnosis and improve the rule out of AMI patients. There is a relationship between AMI and the state of hypercoagulation and/or thrombosis process. sFM is a protrombotic marker that is found to be associated with early AMI incidence compared to cTnI that increases after mionecrosis. The aim of this study is to determine that sFM can be used as biomarker for AMI and the correlation between sFM and cTnI.

Methods. A cross-sectional analytic observational study was conducted among 23 AMI patients and 27 healthy controls. AMI were established using clinical, ECG and laboratory findings. sFM levels were measured with Stago Compact Max analyzer. Statistical analysis was performed using the Spearman’s correlation coefficient, ROC curve analysis, and 2x2 contingency table.

Results. A significant correlation were found between the sFM and the cTnI (r=0.422, p<0.05). With a sFM cutoff level of 2.56 µg/mL, AMI could be diagnosed with sensitivity and specificity of 82.6% and 40.7%, respectively (AUC=0,638).

Discussion. sFM is a new biomarker for systemic thrombus events, both cardiac and non-cardiac.

Conclusions and Suggestions. sFM can be considered as an parameter of AMI. Similar studies with cohort method involving large number may be needed in the future study.



sFM, AMI, cTnI, Biomarker


Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocar¬dial infarction. Eur Heart J 2012; 33: 2551-67.

Santos-Gallego CG, Picatoste B, Badimón JJ. Pathophysiology of acute coronary syndrome. Current atherosclerosis reports. 2014 Apr 1;16(4):401..

Islam S, Yakout SM, Al Daghri NM, Alhomida AS, Khan HA. Serum levels of thrombotic markers in patients with acute myocardial infarction. Int J Clin Exp Med 2014; 7: 1059-63.

Bottiger BW, Snyder-Ramos SA, Lapp W, Motsch J, Aulmann M, Schweizer M, Layug EL, Martin E, Mangano DT. Association between early postoperative coagulation activation and peri-operative myocardial ischaemia in patients undergoing vascular surgery. Anaes-thesia 2005; 60: 1162-67.

Mega JL, Morrow DA, de Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS. Thrombus precur¬sor protein and clinical outcomes in patients with acute coronary syndromes. J Am Coll Card 2008; 51: 2422-9.

Saigo M, Waters DD, Abe S, Biro S, Minagoe S, Maruyama I and Tei C. Soluble fibrin, C-reactive protein, fibrinogen, factor VII, antithrombin, proteins C and S, tissue factor, D-dimer, and prothrombin fragment 1 + 2 in men with acute myocardial infarction ≤ 45 years of age. Am J Cardiol 2004; 94: 1410-1413.

Elged AA, El-Gamal RA, Bastawy S, Moselhy MS. Soluble fibrin monomer complex assay enhances early and accurate diagnosis of acute myocardial infarction. Int J Clin Exp Pathol. 2016 Jan 1;9(5):5801-9.

Venge P, Lindahl B. Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on out¬come prediction. Clin Chem 2013; 59: 976-81

Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54-61

Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M, Hasin Y, Biasucci LM, Giannitsis E, Lindahl B, Koenig W, Tubaro M, Collinson P, Katus H, GalvaniM, Venge P, Alpert JS, Hamm C, Jaffe AS; Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardi¬ac care. Eur Heart J 2010; 31: 2197-204.

Tamura H, Hirono O, Okuyama H, Liu L, Nishiyama S, Takeishi Y, et al.. Elevated serum fibrin-monomer levels are associated with long-term cerebrovascular event rates in acute ischemic stroke patients. Circ J 2007; 71: 1573-79.

Ieko M, Naito S, Mika Y, Kanazawa K, Mizukami K, Sato K, et.al.. Plasma Soluble Fibrin Monomer Complex as a Marker of Coronary Thrombotic Events in Patients with Acute Myocardial Infaction. Tohoku J. Exp. Med. 2009; 219: 25-31.

Weisel JW, Litvinov RI. Mechanisms of fibrin polymerization and clinical implications. Blood. 2013 Jan 1:blood-2012.

Litvinov RI and Weisel JW. What is the biological and clinical relevance of fibrin. Semin Thromb Hemost; 2016: 42 (4): 333 – 343.

DOI: http://dx.doi.org/10.24293/ijcpml.v25i3.1505


  • There are currently no refbacks.